Elysia Thornton

Dr Elysia is a clinically practising Specialist GP/Primary Care and Cancer Survivorship Physician and Clinician Researcher. In addition to her varied GP work, managing all ages and health conditions, including preventative health and wellness, Dr Elysia is passionate and involved nationally in cancer survivorship. Prior to entering GP training, Elysia had a broad hospital oncology experience working across medical oncology, haematology  and melanoma/surgical oncology fields, plus spent 2 years as an advanced trainee in Radiation Oncology. Additionally she has experience working in community palliative care. 

Dr Elysia is involved in cancer survivorship projects and initiatives and over the years has contributed to multiple national and local cancer survivorship advisory boards and groups including the Clinical Oncology Society of Australia (COSA) Survivorship Executive group, was a co-author of the updated COSA position statement on Exercise in Cancer Care, the COSA and Cardiac Society of Australia and New Zealand (CSANZ) Cardio-oncology group as well as the Primary Health Network GPCanShare project and a recent member of the Cancer Council of NSW Health Services Advisory Group. She has worked as a University of NSW Research Fellow providing primary care input to multidisciplinary team meetings and related research for survivors of childhood cancers through the Engage and EngageBrain projects. 

 Dr Elysia has co-authored various cancer survivorship publications, and has been an invited presenter/co-chair at related international conferences. 

Through personal and professional experience, Dr Elysia has insights into the experiences of those living with cancer, survivors of cancer and their carers/family members. It is imperative that workplaces have awareness of the impacts of cancer in a holistic sense, and how best they can support their workers and colleagues through the journey and regarding continuing and/or returning to work. LiveWorkCancer is one such initiative that can help workplaces be “CancerKind”, while also providing networking and support for those facing some of the challenges of cancer.